Literature DB >> 25554609

First one-step nucleic acid amplification testing in papillary thyroid cancer lymph nodes - a comparison with histopathology and real-time PCR.

Krzysztof Kaczka1, Wojciech Fendler, Maciej Borowiec, Wojciech Młynarski, Lech Pomorski.   

Abstract

INTRODUCTION: The significance of lymph node metastases and the optimal extent of lymphadenectomy remain matters of controversy in papillary thyroid cancer. This study was designed to assess the feasibility and reliability of OSNA and real-time PCR for CK19 and TG mRNA in papillary thyroid cancer lymph nodes evaluation compared to standard histopathology.
MATERIAL AND METHODS: Each of 92 randomised lymph nodes from 32 papillary thyroid cancer patients were divided into representative parts and assessed using the three studied methods.
RESULTS: Eighteen (19.6%) lymph nodes from ten (31.3%) patients were positive according to histopathology. When the cut-off value distinguishing metastatic from non-metastatic lymph nodes in the OSNA assay was set at 250 copies per microlitre, the results were positive in 16 (17.4%) lymph nodes from 11 (34.4%) patients. Twenty three (25%) lymph nodes were tested positive in real-time PCR for TG mRNA. Real-time PCR for CK19 mRNA was positive in 18 (19.6%) lymph nodes from 13 (40.6%) patients. No statistically significant differences were noted between the diagnostic accuracy of either molecular method compared to the histopathological examination (p = 0.81). Overall, 20 positive molecular biology results were noted in patients with negative histopathology results. Conversely, in 18 lymph nodes, despite a metastasis finding in histopathology, at least one molecular test yielded a negative result.
CONCLUSIONS: It was revealed that OSNA is a reliable technique for the evaluation of lymph node metastases in papillary thyroid cancer. This method was shown to have equivalent accuracy to histopathology and real-time PCR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25554609     DOI: 10.5603/EP.2014.0059

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  4 in total

1.  Survivin DEx3 as a biomarker of thyroid cancers: A study at the mRNA and protein level.

Authors:  Joanna Waligórska-Stachura; Nadia Sawicka-Gutaj; Maciej Zabel; Mirosław Andrusiewicz; Paweł Gut; Agata Czarnywojtek; Marek Ruchała
Journal:  Oncol Lett       Date:  2017-02-10       Impact factor: 2.967

Review 2.  One-step nucleic acid amplification (OSNA): where do we go with it?

Authors:  Yasuhiro Tamaki
Journal:  Int J Clin Oncol       Date:  2016-08-22       Impact factor: 3.402

3.  One-step nucleic acid amplification analysis of sentinel lymph nodes in papillary thyroid cancer patients.

Authors:  Krzysztof A Kaczka; Lech Pomorski
Journal:  Arch Med Sci       Date:  2017-01-25       Impact factor: 3.318

4.  The Diagnostic Accuracy of One-Step Nucleic Acid Amplification for Lymph Node Metastases of Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Xiaofei Wang; Xun Zheng; Jingqiang Zhu; Zhihui Li; Tao Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-04       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.